Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shandong Weigao Group Medical Polymer CoSHWGF 57 5-Year Yield-on-Cost % is 7.83 as of Jul. 14, 2026, which is 207% above its 10-year median of 2.55. GuruFocus rates SHWGF with a GF Score™ of 57/100 and a GF Value™ of $0.83 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 327 Medical Devices & Instruments companies, Shandong Weigao Group Medical Polymer Co ranks better than 86.54% on this metric.
SHWGF's 5-Year Yield-on-Cost % is ranked better than 86.54% of 327
companies
in the Medical Devices & Instruments industry
Industry Median: 2.33
vs SHWGF: 7.83
Shandong Weigao Group Medical Polymer Co (OTCPK:SHWGF) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Shandong Weigao Group Medical Polymer Co 5-Year Yield-on-Cost % Related Terms
SHWGF vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Group Medical Polymer Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's 5-Year Yield-on-Cost % falls into.
Shandong Weigao Group Medical Polymer Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Shandong Weigao Group Medical Polymer Co (SHWGF) has a 5-Year Yield-on-Cost % of 7.83 as of Jul. 14, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. This is 207% above median its historical median of 2.55. Over the past decade, Shandong Weigao Group Medical Polymer Co's 5-Year Yield-on-Cost % has ranged from 0.90 to 11.94. According to the industry distribution chart, Shandong Weigao Group Medical Polymer Co ranks #44 out of 327 companies in the Medical Devices & Instruments industry, placing it in the top 13.5%.
Is Shandong Weigao Group Medical Polymer Co's 5-Year Yield-on-Cost % too high?
Shandong Weigao Group Medical Polymer Co's current 5-Year Yield-on-Cost % of 7.83 is 207% above median its 10-year median of 2.55. Over the past 10 years, this metric has ranged from a low of 0.90 to a high of 11.94. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.33. Shandong Weigao Group Medical Polymer Co's value of 7.83 is 236.1% above this industry median. Based on the distribution chart, Shandong Weigao Group Medical Polymer Co ranks #44 out of 327 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Weigao Group Medical Polymer Co has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Group Medical Polymer Co's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shandong Weigao Group Medical Polymer Co ranks #44 out of 327 companies for 5-Year Yield-on-Cost %. This places Shandong Weigao Group Medical Polymer Co in the top 14% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.33. Shandong Weigao Group Medical Polymer Co's value of 7.83 is 236.1% above this benchmark. Historically, Shandong Weigao Group Medical Polymer Co's own 5-Year Yield-on-Cost % has ranged from 0.90 to 11.94 over the past decade. While the company's 10-year median is 2.55 vs. the industry median of 2.33, Shandong Weigao Group Medical Polymer Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.33, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Weigao Group Medical Polymer Co's current 5-Year Yield-on-Cost % of 7.83 is 236.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Weigao Group Medical Polymer Co's current 5-Year Yield-on-Cost % is 7.83, which is 207% above median its own 10-year median of 2.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Group Medical Polymer Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co (SHWGF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.83, compared to a current price of $0.43 — trading 47.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 7.83, which is 207% above median its 10-year median of 2.55 and 236.1% above the Medical Devices & Instruments industry median of 2.33. Shandong Weigao Group Medical Polymer Co's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Shandong Weigao Group Medical Polymer Co (SHWGF), the current 5-Year Yield-on-Cost % is 7.83 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Weigao Group Medical Polymer Co (SHWGF) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co stock appears to be undervalued.
The current stock price of $0.43 is trading 47.7% below its estimated GF Value™ of $0.83.
GuruFocus considers Shandong Weigao Group Medical Polymer Co to be Significantly Undervalued.
Key valuation signals for SHWGF:
5-Year Yield-on-Cost %: 7.83 (207% above median its 10-year median of 2.55)
GF Value™: $0.83 vs. price of $0.43 (47.7% below fair value)
Industry Position: 236.1% above the Medical Devices & Instruments median (#44 of 327)
No single metric tells the full story. See the SHWGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Weigao Group Medical Polymer Co Business Description
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
57GF Score
Get the complete analysis for SHWGF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHWGF has been successfully added to your 
